Page 2 - Libre Sense News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Abbott Labs Board Chairman/CEO Robert Ford gives the first keynote address by a healthcare company representative in CES history.

Strength in Diabetes Care and Diagnostics businesses is driving Abbott's (ABT) top line.

Author Bio Adria Cimino grew up with her nose in a book and a love of storytelling. By a twist of fate, she started her career writing about biotech in Boston and discovered that each company is the source of many fascinating stories. Prior to joining The Fool as a contract writer focused on healthcare and consumer goods, Adria covered the stock market for Bloomberg News in Paris. When she’s not analyzing companies, she can be found writing fiction or trying to speak French as well as her 9-year-old daughter. Follow @adria_in_paris Coronavirus-vaccine mak...

Share this article Share this article ATLANTA, April 27, 2021 /PRNewswire/ -- Supersapiens announces a $13.5 million capital raise led by MICA Ventures AG. The new energy management ecosystem, powered by Abbott's Libre Sense Glucose Sport Biosensor, has secured the largest investment in the sports continuous glucose monitoring (CGM) space, garnering investment from preeminent fitness and performance brands including the founder of Zwift and Wahoo. Supersapiens Closes $13.5 Million in Early-Stage Funding Joining lead investor Michael Hartweg, founder of MICA Ventures AG, is Ed Baker, former V...

Share this article Share this article ABBOTT PARK, Ill., April 20, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the first quarter ended March 31, 2021. First-quarter sales of $10.5 billion increased 35.3 percent on a reported basis and 32.9 percent on an organic basis, which excludes the impact of foreign exchange. First-quarter GAAP diluted EPS was $1.00 and adjusted diluted EPS, which excludes specified items, was $1.32, reflecting 103.1 percent growth versus the prior year. 1 Abbott projects full-year 2021 diluted EPS from continuing operations on a GAAP...